CEP 701,
CEP-701,
CEP701,
KT-5555,
KT5555,
lestaurtinib,
Lestaurtinib,
111358-88-4,
CEP-701,
KT-5555,
CEP 701,
KT5555,
SP 924,
KT 5555,
SP924,
UNII-DO989GC5D1,
SPM-924,
CHEMBL603469,
DO989GC5D1,
C26H21N3O4,
SP-924,
NCGC00168772-01,
9,12-Epoxy-1H-diindolo[1,2,3-fg:3',2',1'-kl]pyrrolo[3,4-i][1,6]benzodiazocin-1-one, 2,3,9,10,11,12-hexahydro-10-hydroxy-10-(hydroxymethyl)-9-methyl-, (9S,10S,12R)-,
Lestaurtinib (USAN/INN),
Lestaurtinib [USAN:INN],
CEP701,
4otg,
9,12-Epoxy-1H-diindolo(1,2,3-fg:3',2',1'-kl)pyrrolo(3,4-i)(1,6)benzodiazocin-1-one, 2,3,9,10,11,12-hexahydro-10-hydroxy-10-(hydroxymethyl)-9-methyl-, (9S,10S,12R)-,
A 1544750,
KT5555-Lestaurtinib,
A-1544750,
DSSTox_CID_26778,
DSSTox_RID_81897,
DSSTox_GSID_46778,
cc-713,
GTPL5672,
SCHEMBL1649693,
DTXSID5046778,
CHEBI:91471,
CTK8F0849,
BIL2000,
UIARLYUEJFELEN-LROUJFHJSA-N,
BCP06977,
ZINC3781738,
Tox21_112633,
BDBM50308060,
KT-555,
MFCD09840836,
MFCD12828858,
AKOS024457603,
AC-5243,
AM81228,
NCGC00168772-02,
NCGC00168772-03,
NCGC00168772-04,
AN-11201,
HY-50867,
RT-013568,
CAS-111358-88-4,
CS-0004336,
FT-0670762,
V0246,
D04696,
A-154475,
J-002567,
BRD-K23192422-001-01-1,
A 154475.0,
A-154475.0,
(15S,16S,18R)-16-hydroxy-16-(hydroxymethyl)-15-methyl-28-oxa-4,14,19-triazaoctacyclo[12.11.2.1^{15,18}.0^{2,6}.0^{7,27}.0^{8,13}.0^{19,26}.0^{20,25}]octacosa-1(26),2(6),7(27),8,10,12,20,22,24-nonaen-3-one,
(5R,7S,8S)-7-hydroxy-7-(hydroxymethyl)-8-methyl-5,6,7,8,13,14-hexahydro-15H-16-oxa-4b,8a,14-triaza-5,8-methanodibenzo[b,h]cycloocta[jkl]cyclopenta[e]-as-indacen-15-one,
(5S,6S,8R)-6-hydroxy-6-(hydroxymethyl)-5-methyl-7,8,14,15-tetrahydro-5H-16-oxa-4b,8a,14-triaza-5,8-methanodibenzo[b,h]cycloocta[jkl]cyclopenta[e]-as-indacen-13(6H)-one,
(9S,10S,12R)-10-Hydroxy-10-(hydroxymethyl)-9-methyl-2,3,9,10,11,12-hexahydro-9,12-epoxy-1H-diindolo(1,2,3-fg:3',2',1'-kl)pyrrolo(3,4-i)(1,6)benzodiazocin-1-one,
(9S,10S,12R)-2,3,9,10,11,12-Hexahydro-10-hydroxy-10-(hydroxymethyl)-9-methyl-9,12-epoxy-1H-diindolo[1,2,3-fg:3 inverted exclamation mark ,2 inverted exclamation mark ,1 inverted exclamation mark -kl]pyrrolo[3,4-i][1,6]benzodiazocin-1-one,
(9S,10S,12R)-2,3,9,10,11,12-Hexahydro-10-hydroxy-10-(hydroxymethyl)-9-methyl-9,12-epoxy-1H-diindolo[1,2,3-fg:3',2',1'-kl]pyrrolo[3,4-i][1,6]benzodiazocin-1-one,
16-hydroxy-16-(hydroxymethyl)-15-methyl-28-oxa-4,14,19-triazaoctacyclo[12.11.2.1^{15,18}.0^{2,6}.0^{7,27}.0^{8,13}.0^{19,26}.0^{20,25}]octacosa-1(26),2(6),7(27),8(13),9,11,20(25),21,23-nonaen-3-one,
2-(((((4-ethoxy-6-(methylamino)-1,3,5-triazin-2-yl)amino)carbonyl)amino)sulfonyl)benzoic acid,
9,12-Epoxy-1H-diindolo(1,2,3-fg:3',2',1'-kl)pyrrolo(3,4-i)(1,6)benzodiazocin-1-one, 2,3,9,10,11,12-hexahydro-10-hydroxy-10-(hydroxymethyl)-9-methyl-, (9S-(9alpha,10beta,12alpha))-,
CEP-701|||KT-5555|||(5S,6S,8R)-6-Hydroxy-6-(hydroxymethyl)-5-methyl-7,8,14,15-tetrahydro-5H-16-oxa-4b,8a,14-triaza-5,8-methanodibenzo[b,h]cycloocta[jkl]cyclopenta[e]-as-indacen-13(6H)-one,
Lestaurtinib [USAN],
D0V9WF,
CID126565,
C26-H21-N3-O4,
A4513,
C119379,
2V9,